September 29, 2026 09:35 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
SIR row: Supreme Court to hear plea against CEC Gyanesh Kumar next week | Sambhal violence case: SC quashes key accused Mulla Afroz's NSA detention, slaps Rs 10 lakh cost on UP govt | Nandigram bypoll twist: Calcutta HC grants interim bail to Congress candidate Milan Pradhan till Oct 21 | Myanmar military airstrike horror: 49 killed, 58 injured as bombs hit crowded Rakhine market | Britain reopens refugee routes for Afghans, Palestinians as immigration and integration battle intensifies | New York Times executive shot dead: Elderly in-laws arrested amid bitter family feud over his 'trans' identity | Vijay's TVK makes Bengal entry: First party office opens in Purba Bardhaman amid state's political shake-up | SRFTI clash erupts over ABGP event: Students allege assault; BJP calls it ‘ugly face of Leftists’ | 'Asif bhai gun nikal': 17-year-old's chilling account of men posing as cops raping her in South Delhi park | Indian passport rules changed: New validity, fees for children and adults explained
Pixabay

US approved 4 COVID-19 vaccine candidates for clinical trials: FDA Head

| @indiablooms | Jul 01, 2020, at 09:58 am

Washington/Sputnik: The United States has approved four coronavirus vaccine candidates for clinical trials, Food and Drug Administration (FDA) head Stephen Hahn told reporters.

“Four vaccines have been approved for moving into clinical trials... and another six are in the pipeline for us to review,” Hahn said during a press briefing on Tuesday.

The US Administration launched in May Operation Warp Speed, a joint project of Health and Defense Departments, which aims to deliver 300 million doses of a vaccine for COVID-19 by January 2021.

The country’s top pandemics expert Anthony Fauci warned on Tuesday, however, that there is no certainty the United States will be able to develop a vaccine against COVID-19 that works and will be safe.

Data on vaccine effectiveness, he added, may be available in the winter or early next year.  

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.